(Q61938110)

English

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

BEGIN™ (English)

0 references

title

A 26-week Randomised, Confirmatory, Controlled, Open Label, Multicentre, Multinational Treat-to-target Trial Comparing the Efficacy and Safety of SIBA 200 U/ml Three Times Weekly Injected in the Evening and Insulin Glargine Once Daily in a Population of Insulin naïve Subjects With Type 2 Diabetes Mellitus Currently Treated With OADs Qualifying for Intensified Treatment (BEGIN™: EASY™) (English)

0 references

0 references

0 references

0 references

0 references